TICKERNOMICS Sign up
Last Update: 2023-12-23 06:03:22
Longeveron Inc. ( LGVN ) https://www.longeveron.com
1.25USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-61.77%
LGVN
SPY
30.72%
LGVN
0.00%
SPY
112.82%
LGVN
0.00%
SPY
201.04%
LGVN
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
40.88
43.84
1.19
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-2.06
53.29
6.16
-67.30
0.00
-2.19
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-3440.67
36.00
-2606.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
3.86
-88.14
-66.29
0.00
Other Earnings and Cash Flow Stats:
Longeveron Inc. ( LGVN ) Net Income TTM ($MM) is -19.55
Longeveron Inc. ( LGVN ) Operating Income TTM ($MM) is -20.30
Longeveron Inc. ( LGVN ) Owners' Earnings Annual ($MM) is 0.00
Longeveron Inc. ( LGVN ) Current Price to Owners' Earnings ratio is 0.00
Longeveron Inc. ( LGVN ) EBITDA TTM ($MM) is -19.50
Longeveron Inc. ( LGVN ) EBITDA Margin is -2606.00%
Capital Allocation:
Longeveron Inc. ( LGVN ) has paid 0.00 dividends per share and bought back -0.177154 million shares in the past 12 months
Longeveron Inc. ( LGVN ) has reduced its debt by 0.552 million USD in the last 12 months
Capital Structure:
Longeveron Inc. ( LGVN ) Interest-bearing Debt ($MM) as of last quarter is 4
Longeveron Inc. ( LGVN ) Annual Working Capital Investments ($MM) are -8
Longeveron Inc. ( LGVN ) Book Value ($MM) as of last quarter is 6
Longeveron Inc. ( LGVN ) Debt/Capital as of last quarter is 30%
Other Balance Sheet Stats:
Longeveron Inc. ( LGVN ) has 1 million in cash on hand as of last quarter
Longeveron Inc. ( LGVN ) has 3 million of liabilities due within 12 months, and long term debt 1 as of last quarter
Longeveron Inc. ( LGVN ) has 21 common shares outstanding as of last quarter
Longeveron Inc. ( LGVN ) has 0 million USD of preferred stock value
Academic Scores:
Longeveron Inc. ( LGVN ) Altman Z-Score is -10.27 as of last quarter
Longeveron Inc. ( LGVN ) Piotroski Score is 4.00 as of last quarter
Corporate Governance:
Longeveron Inc. ( LGVN ) largest shareholder is Northern Trust Corp owning 10623 shares at 0.01 ($MM) value
James Clavijo(an insider) Sold 5000 shares of Longeveron Inc. ( LGVN ) for the amount of $17550.00 on 2023-06-29
18.36% of Longeveron Inc. ( LGVN ) is held by insiders, and 8.57% is held by institutions
Longeveron Inc. ( LGVN ) went public on 2021-02-12
Other Longeveron Inc. ( LGVN ) financial metrics:
FCF:-17.82
Unlevered Free Cash Flow:0.00
EPS:-1.12
Operating Margin:-3440.67
Gross Profit Margin:36.00
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-356.09
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Longeveron Inc. ( LGVN ) :
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, an allogeneic medicinal signaling cell therapy product isolated from the bone marrow of young, healthy adult donors. It is conducting Phase 1, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is headquartered in Miami, Florida.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.